Tumors with aberrant p53 expression (Figure 2(f)) were more frequent (62%) in the CIN subtype compared with other subtypes (33% in MSI, 38% in EBV, and 39% in GS subtype). The gene discussed is TP53; the disease is cervical squamous intraepithelial neoplasia.